RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection

被引:3
作者
Talukder, Pratik [1 ]
Chanda, Sounak [1 ]
机构
[1] Univ Engn & Management, Dept Biotechnol, St 03,Act Area 3,B-5, Kolkata 700156, W Bengal, India
关键词
COVID-19; Vaccine; ACE2; receptors; Antibody; Antigen; siRNA; Gene silencing; RESPIRATORY SYNDROME CORONAVIRUS; SARS-COV; PROTEIN; IDENTIFICATION; NANOCARRIERS; MODEL; MICE;
D O I
10.1007/s12010-021-03548-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Coronavirus disease of 2019 (COVID-19) pandemic, taking place globally, occurs as a result of the SARS-CoV-2 viral infection which has caused death of innumerable numbers of people and is responsible for a massive drop in the global economy. Millions of people are infected, and the death rate is also quite high in different countries. So, there is an urgent requirement of the invention of some effective and efficient drugs that can be effective against this deadly viral infection. The invention of new drugs and vaccine has become a matter of utmost importance to stop the mayhem of coronavirus pandemic. In the middle of such a deadly pandemic, the necessity of development of a vaccine is of high importance in this context. Among all the popular methods of vaccine development, the mRNA vaccines turned out to be the one of the most versatile vaccine with quick responses. However, in this review, we have explained all the possible types of vaccines available including DNA vaccines, RNA vaccines, and live and attenuated vaccines. Their effectiveness, importance, and application of the vaccines against the SARS-CoV-2 virus have been discussed. Research is also being conducted in the field of gene silencing, and one of the best possible ways to combat the virus at the molecular level is by applying RNAi technology. The modified siRNA molecules can be used to silence the gene expression of the virus. A summarization of the virus's behavior, characteristics, and the methods by which RNAi technology can be administered to control the virus is depicted in this study.
引用
收藏
页码:1744 / 1756
页数:13
相关论文
共 50 条
  • [41] Variants of SARS-CoV-2: Influences on the Vaccines' Effectiveness and Possible Strategies to Overcome Their Consequences
    Rabaan, Ali A.
    Al-Ahmed, Shamsah H.
    Albayat, Hawra
    Alwarthan, Sara
    Alhajri, Mashael
    Najim, Mustafa A.
    AlShehail, Bashayer. M.
    Al-Adsani, Wasl
    Alghadeer, Ali
    Abduljabbar, Wesam A.
    Alotaibi, Nouf
    Alsalman, Jameela
    Gorab, Ali H.
    Almaghrabi, Reem S.
    Zaidan, Ali A.
    Aldossary, Sahar
    Alissa, Mohammed
    Alburaiky, Lamees M.
    Alsalim, Fatimah Mustafa
    Thakur, Nanamika
    Verma, Geetika
    Dhawan, Manish
    MEDICINA-LITHUANIA, 2023, 59 (03):
  • [42] Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
    Abbott, Timothy R.
    Dhamdhere, Girija
    Liu, Yanxia
    Lin, Xueqiu
    Goudy, Laine
    Zeng, Leiping
    Chemparathy, Augustine
    Chmura, Stephen
    Heaton, Nicholas S.
    Debs, Robert
    Pande, Tara
    Endy, Drew
    La Russa, Marie F.
    Lewis, David B.
    Qi, Lei S.
    CELL, 2020, 181 (04) : 865 - +
  • [43] A Review of Recent Studies on the Effects of SARS-CoV-2 Infection and SARS-CoV-2 Vaccines on Male Reproductive Health
    Adamyan, Leila
    Elagin, Vladimir
    Vechorko, Valeriy
    Stepanian, Assia
    Dashko, Anton
    Doroshenko, Dmitriy
    Aznaurova, Yana
    Sorokin, Maxim
    Garazha, Andrew
    Buzdin, Anton
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [44] Cannabidiol and SARS-CoV-2 Infection
    Vallee, Alexandre
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Histopathological features of SARS-CoV-2 infection and relationships with organoid technology
    Inanc, Irem
    Erdemli, Esra
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (09)
  • [46] In the eye of the storm: SARS-CoV-2 infection and replication at the ocular surface?
    Armstrong, Lyle
    Collin, Joseph
    Mostafa, Islam
    Queen, Rachel
    Figueiredo, Francisco C.
    Lako, Majlinda
    STEM CELLS TRANSLATIONAL MEDICINE, 2021, 10 (07) : 976 - 986
  • [47] SARS-CoV-2 Variants and Vaccines
    Krause, Philip R.
    Fleming, Thomas R.
    Longini, Ira M.
    Peto, Richard
    Briand, Sylvie
    Heymann, David L.
    Beral, Valerie
    Snape, Matthew D.
    Rees, Helen
    Ropero, Alba-Maria
    Balicer, Ran D.
    Cramer, Jakob P.
    Munoz-Fontela, Cesar
    Gruber, Marion
    Gaspar, Rogerio
    Singh, Jerome A.
    Subbarao, Kanta
    Van Kerkhove, Maria D.
    Swaminathan, Soumya
    Ryan, Michael J.
    Henao-Restrepo, Ana-Maria
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02) : 179 - 186
  • [48] SARS-CoV-2 Vaccines and the Skin
    Galvan-Casas, C.
    Catala, A.
    Munoz-Santos, C.
    ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (09): : 828 - 836
  • [49] SARS-CoV-2 vaccines and myocarditis
    Sularz, Agata Katarzyna
    Hua, Alina
    Ismail, Tevfik
    CLINICAL MEDICINE, 2023, 23 (05) : 495 - 502
  • [50] Immune response scenario and vaccine development for SARS-CoV-2 infection
    Mohammad, Mai H. S.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 94